» Articles » PMID: 29334727

ApoB/ApoA-I Ratio is Independently Associated with Carotid Atherosclerosis in Type 2 Diabetes Mellitus with Well-controlled LDL Cholesterol Levels

Overview
Specialty General Medicine
Date 2018 Jan 17
PMID 29334727
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: This study aimed to investigate whether the apolipoprotein (Apo) B/ApoA-I ratio is associated with carotid intima-media thickness (CIMT) in type 2 diabetes mellitus (T2DM) subjects with low density lipoprotein cholesterol (LDL-C) levels less than 100 mg/dL.

Methods: This cross-sectional study included 845 subjects aged with T2DM 40 to 75 years who had visited Huh's Diabetes Center in Seoul, Republic of Korea for CIMT measurement. Traditional fasting lipid profiles, ApoB and ApoA-I levels were examined. CIMT was measured at three points on the far wall of 1 cm long section of the common carotid artery in the proximity of the carotid bulb. The mean value of six measurements from right and left carotid arteries were used as the mean CIMT. In this study, carotid atherosclerosis was defined as having a focal plaque or diffuse thickening of the carotid wall (mean CIMT ≥ 1.0 mm).

Results: The prevalence of carotid atherosclerosis increased with ApoB/ApoA-I ratio. The ApoB/ApoA-I ratio, expressed as both quartiles (odds ratio [OR], 2.14; 95% confidence interval [CI], 1.21 to 3.79; for trend = 0.014) and continuous values (OR, 10.05; 95% CI, 3.26 to 30.97; < 0.001), was significantly associated with a higher risk for carotid atherosclerosis, regardless of conventional cardiovascular disease risk factors. The optimal ApoB/ApoA-I ratio cutoff value for detecting carotid atherosclerosis was 0.57, based on receiver operating characteristic curve analysis with a sensitivity of 58.0% and a specificity of 55.1%.

Conclusions: A high ApoB/ApoA-I ratio was significantly associated with carotid atherosclerosis in T2DM patients with LDL-C levels less than 100 mg/dL.

Citing Articles

Serum apolipoprotein B to apolipoprotein A-I ratio predicts mortality in patients with heart failure.

Li S, Xie X, Zeng X, Wang S, Lan J ESC Heart Fail. 2023; 11(1):99-111.

PMID: 37822135 PMC: 10804159. DOI: 10.1002/ehf2.14547.


Effectiveness of Non-Contact Dietary Coaching in Adults with Diabetes or Prediabetes Using a Continuous Glucose Monitoring Device: A Randomized Controlled Trial.

Ahn Y, Kim Y, Kim B, Ryu J, Kim M, Kang M Healthcare (Basel). 2023; 11(2).

PMID: 36673620 PMC: 9859545. DOI: 10.3390/healthcare11020252.


Effect of Apolipoprotein E ε4 Allele on the Progression of Carotid Atherosclerosis Through Apolipoprotein Levels.

Ma W, Zhang L, Luo L, Zhang S, Yang S, Yao H Pharmgenomics Pers Med. 2022; 15:653-661.

PMID: 35761854 PMC: 9233493. DOI: 10.2147/PGPM.S367471.


Association of Lower Extremity Vascular Disease, Coronary Artery, and Carotid Artery Atherosclerosis in Patients with Type 2 Diabetes Mellitus.

Yang Z, Han B, Zhang H, Ji G, Zhang L, Singh B Comput Math Methods Med. 2021; 2021:6268856.

PMID: 34697555 PMC: 8541854. DOI: 10.1155/2021/6268856.


Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol.

Fonseca L, Paredes S, Ramos H, Oliveira J, Palma I Lipids Health Dis. 2020; 19(1):127.

PMID: 32505210 PMC: 7275418. DOI: 10.1186/s12944-020-01292-w.


References
1.
Ivanova E, Myasoedova V, Melnichenko A, Grechko A, Orekhov A . Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases. Oxid Med Cell Longev. 2017; 2017:1273042. PMC: 5441126. DOI: 10.1155/2017/1273042. View

2.
Dahlen E, Lanne T, Engvall J, Lindstrom T, Grodzinsky E, Nystrom F . Carotid intima-media thickness and apolipoprotein B/apolipoprotein A-I ratio in middle-aged patients with Type 2 diabetes. Diabet Med. 2009; 26(4):384-90. DOI: 10.1111/j.1464-5491.2009.02693.x. View

3.
Kim S, Choi Y, Huh B, Kim C, Park S, Lee E . Ratio of waist-to-calf circumference and carotid atherosclerosis in Korean patients with type 2 diabetes. Diabetes Care. 2011; 34(9):2067-71. PMC: 3161258. DOI: 10.2337/dc11-0743. View

4.
Kaneva A, Potolitsyna N, Bojko E, Odland J . The apolipoprotein B/apolipoprotein A-I ratio as a potential marker of plasma atherogenicity. Dis Markers. 2015; 2015:591454. PMC: 4380097. DOI: 10.1155/2015/591454. View

5.
Naqvi T, Lee M . Carotid intima-media thickness and plaque in cardiovascular risk assessment. JACC Cardiovasc Imaging. 2014; 7(10):1025-38. DOI: 10.1016/j.jcmg.2013.11.014. View